Offshore
Photo
Dimitry Nakhla | Babylon Capital®
ServiceNow trades 25x NTM FCF Est 💵
2026E: $5.39B (+20% YoY)
2027E: $6.52B (+20% YoY)
2028E: $7.69B (+18% YoY)
$NOW https://t.co/FAKpzSQpXX
tweet
ServiceNow trades 25x NTM FCF Est 💵
2026E: $5.39B (+20% YoY)
2027E: $6.52B (+20% YoY)
2028E: $7.69B (+18% YoY)
$NOW https://t.co/FAKpzSQpXX
tweet
Offshore
Photo
Illiquid
A lot of everything chip related happens in Malaysia.
tweet
A lot of everything chip related happens in Malaysia.
Many people are not aware that $INTC does much of their #AdvancedPackaging in Malaysia.
The ChipBook tracks exports of HBM from Korea to Malaysia to keep tabs on the latest Intel developments.
https://t.co/oD6GEdN2av https://t.co/M9XoUfYsdT tweet
Offshore
Photo
The Few Bets That Matter
$TMDX dropped yesterday after news that a new competitor got FDA approval for perfusion after cold storage.
Bridge to Life’s VitaSmart was cleared for Hypothermic Oxygenated Machine Perfusion, allowing their machine to perfuse organs post cold storage, potentially allowing DCD liver transplants.
The market’s fear: a cheaper cold storage + perfusion setup could largely reduce costs and bring real competition.
But the market is ignoring a lot...
🔹OCS has consistently shown better outcomes. The device cost is negligible compared to the total cost of a failing organ (dialysis, long-term care, retransplant risk, etc)...
🔹The control of the organ's viability, automated actions and better planifications in term of surgery planning as a cold storage requires urgent intervention - hence added costs.
🔹It also ignores logistics. OCS simplifies transport, improves workflows, delivers end-to-end cost savings versus stitching together 4–5 vendors, each taking their own margin.
🔹And habits. Once a hospital owns and works with an OCS, consumables aren’t the real cost driver. Combined with better outcomes and simpler workflows, switching just doesn’t make much sense.
Yes, new cold storage solutions add competition. But they’re not a threat to $TMDX long-term potential, they are an old technology which will be used for a few more years and then be forgotten to innovation.
At best, they’re a short-term, cost-efficient alternative.
tweet
$TMDX dropped yesterday after news that a new competitor got FDA approval for perfusion after cold storage.
Bridge to Life’s VitaSmart was cleared for Hypothermic Oxygenated Machine Perfusion, allowing their machine to perfuse organs post cold storage, potentially allowing DCD liver transplants.
The market’s fear: a cheaper cold storage + perfusion setup could largely reduce costs and bring real competition.
But the market is ignoring a lot...
🔹OCS has consistently shown better outcomes. The device cost is negligible compared to the total cost of a failing organ (dialysis, long-term care, retransplant risk, etc)...
🔹The control of the organ's viability, automated actions and better planifications in term of surgery planning as a cold storage requires urgent intervention - hence added costs.
🔹It also ignores logistics. OCS simplifies transport, improves workflows, delivers end-to-end cost savings versus stitching together 4–5 vendors, each taking their own margin.
🔹And habits. Once a hospital owns and works with an OCS, consumables aren’t the real cost driver. Combined with better outcomes and simpler workflows, switching just doesn’t make much sense.
Yes, new cold storage solutions add competition. But they’re not a threat to $TMDX long-term potential, they are an old technology which will be used for a few more years and then be forgotten to innovation.
At best, they’re a short-term, cost-efficient alternative.
tweet
AkhenOsiris
Anthropic
Wired:
Last year, the business of AI coding agents took off. In November, Anthropic announced that Claude Code had reached $1 billion in annualized recurring revenue, less than a year after its debut.
By the end of 2025, Claude Code’s ARR had grown by at least another $100 million, according to a person familiar with the company’s financials. At the time the product accounted for roughly 12 percent of Anthropic’s total ARR, which stood around $9 billion. While still smaller than Anthropic’s enterprise business—which supplies AI systems to entire corporations—coding is one of the company’s fastest-growing segments.
Anthropic has also told investors it aims to be cash-flow positive by 2028 and that Claude Code could play an important role in its revenue growth. The company declined to comment on its finances.
tweet
Anthropic
Wired:
Last year, the business of AI coding agents took off. In November, Anthropic announced that Claude Code had reached $1 billion in annualized recurring revenue, less than a year after its debut.
By the end of 2025, Claude Code’s ARR had grown by at least another $100 million, according to a person familiar with the company’s financials. At the time the product accounted for roughly 12 percent of Anthropic’s total ARR, which stood around $9 billion. While still smaller than Anthropic’s enterprise business—which supplies AI systems to entire corporations—coding is one of the company’s fastest-growing segments.
Anthropic has also told investors it aims to be cash-flow positive by 2028 and that Claude Code could play an important role in its revenue growth. The company declined to comment on its finances.
tweet
AkhenOsiris
Anthropic:
While Anthropic feels dominant in AI coding, the buzz around Claude Opus 4.5 appears to be lifting several companies. Cursor, which lets users code using models from Anthropic and other AI labs, also said its coding tool reached $1 billion in ARR in November. In December, the company posted particularly strong month-over-month revenue growth, according to a person close to the company.
tweet
Anthropic:
While Anthropic feels dominant in AI coding, the buzz around Claude Opus 4.5 appears to be lifting several companies. Cursor, which lets users code using models from Anthropic and other AI labs, also said its coding tool reached $1 billion in ARR in November. In December, the company posted particularly strong month-over-month revenue growth, according to a person close to the company.
Anthropic
Wired:
Last year, the business of AI coding agents took off. In November, Anthropic announced that Claude Code had reached $1 billion in annualized recurring revenue, less than a year after its debut.
By the end of 2025, Claude Code’s ARR had grown by at least another $100 million, according to a person familiar with the company’s financials. At the time the product accounted for roughly 12 percent of Anthropic’s total ARR, which stood around $9 billion. While still smaller than Anthropic’s enterprise business—which supplies AI systems to entire corporations—coding is one of the company’s fastest-growing segments.
Anthropic has also told investors it aims to be cash-flow positive by 2028 and that Claude Code could play an important role in its revenue growth. The company declined to comment on its finances. tweet
AkhenOsiris
In the public stack, market seems confused how to price in Anthropic news...fairly straightforward how to price in OAI and Gemini...part of it is Anthropic on all clouds and no arrangement similar to OAI/MSFT...just saying
tweet
In the public stack, market seems confused how to price in Anthropic news...fairly straightforward how to price in OAI and Gemini...part of it is Anthropic on all clouds and no arrangement similar to OAI/MSFT...just saying
Anthropic:
While Anthropic feels dominant in AI coding, the buzz around Claude Opus 4.5 appears to be lifting several companies. Cursor, which lets users code using models from Anthropic and other AI labs, also said its coding tool reached $1 billion in ARR in November. In December, the company posted particularly strong month-over-month revenue growth, according to a person close to the company. tweet
Offshore
Video
God of Prompt
RT @prompt_copilot: Your AI finally has a memory.
→ Prompt enhancement
→ Autocomplete
→ Context profiles
Same you. Any AI.
Try it out 👉 https://t.co/TKMMCzVWj1 https://t.co/GMoyDegr59
tweet
RT @prompt_copilot: Your AI finally has a memory.
→ Prompt enhancement
→ Autocomplete
→ Context profiles
Same you. Any AI.
Try it out 👉 https://t.co/TKMMCzVWj1 https://t.co/GMoyDegr59
tweet
Offshore
Photo
The Few Bets That Matter
$BABA is pumping today on talk of a potential IPO of its AI hardware unit.
Think of it like a $GOOG IPO of its TPU business. That’s the scale we’re talking about - not the capacities.
$BABA plans to commercialize its ASICs not just as a rental product, but also to sell them directly for on-prem use by companies.
With $NVDA export curbs and ongoing tensions, this could easily become the go-to AI hardware stack in China. Even Jensen has talked about a rapidly growing ~$50B market.
From a price action standpoint, $BABA has been a gift. Same pattern printed three times. One of the easiest stocks to buy, hold and accumulate over the past two years.
Looking forward to more of this.
You don’t want to miss it, because the breakout will come. And we'll need the convictions to buy in size when it happens. Because it will.
tweet
$BABA is pumping today on talk of a potential IPO of its AI hardware unit.
Think of it like a $GOOG IPO of its TPU business. That’s the scale we’re talking about - not the capacities.
$BABA plans to commercialize its ASICs not just as a rental product, but also to sell them directly for on-prem use by companies.
With $NVDA export curbs and ongoing tensions, this could easily become the go-to AI hardware stack in China. Even Jensen has talked about a rapidly growing ~$50B market.
From a price action standpoint, $BABA has been a gift. Same pattern printed three times. One of the easiest stocks to buy, hold and accumulate over the past two years.
Looking forward to more of this.
You don’t want to miss it, because the breakout will come. And we'll need the convictions to buy in size when it happens. Because it will.
$BABA has been frustrating for many lately.
But there is nothing wrong in consolidation. We're below the trendline, a pattern which has been repeated twice perfectly during 2025.
I’ll share a refreshed bull thesis on China and Alibaba in a few days.
You don’t want to miss it, because the breakout will come. And we'll need the convictions to buy in size when it happens. Because it will.
Patience. tweet
Offshore
Photo
Wasteland Capital
Truflation now at 1.20%.
Meanwhile Q4 GDP tracking at +5.4% (GDPNow), highest since the 2021 post-COVID rebound.
And the S&P500 close to ATH.
How did 95% of economists, journalists and Wall Street macro strategist get it so f**king wrong in April? What happens in their brains?
tweet
Truflation now at 1.20%.
Meanwhile Q4 GDP tracking at +5.4% (GDPNow), highest since the 2021 post-COVID rebound.
And the S&P500 close to ATH.
How did 95% of economists, journalists and Wall Street macro strategist get it so f**king wrong in April? What happens in their brains?
US Inflation has further dropped to 1.20% today.
Main drivers of this latest in a series of disinflationary coolings were:
- Food - mostly Eggs
- Household durables - particularly housekeeping supplies
- Alcohol & tobacco - mostly alcoholic beverages
Our number is derived by aggregating millions of real-time price data points every day to calculate a year-over-year CPI % rate. It is comparable but not identical to the survey-based official headline inflation released monthly by the BLS, which was 2.7% for December. tweet
Offshore
Photo
The Few Bets That Matter
$PATH reacting perfectly on its weekly 50.
Exactly what investors wanted to know. I said this was where bulls had to buy. It's too early to draw conclusions but bulls did step up today.
I certainly did my part. https://t.co/wVZXWCT3vf
tweet
$PATH reacting perfectly on its weekly 50.
Exactly what investors wanted to know. I said this was where bulls had to buy. It's too early to draw conclusions but bulls did step up today.
I certainly did my part. https://t.co/wVZXWCT3vf
$PATH lost what looked like a strong support.
But the real perfect support lies at the weekly 50 around $14, just like it did during the previous leg up.
Patients won. https://t.co/apRPBeqrbe tweet
Offshore
Photo
Moon Dev
24 hours
in 24 hours this program closes and you will never be able to join it again
i show you step by step how to automate your trading and i give you all of my code
you get a community inside discord, direct help, and i even pay for your ai
you also get every course i have ever released
this closes in 24 hours
join here https://t.co/nCYxRkV79w
moon dev
tweet
24 hours
in 24 hours this program closes and you will never be able to join it again
i show you step by step how to automate your trading and i give you all of my code
you get a community inside discord, direct help, and i even pay for your ai
you also get every course i have ever released
this closes in 24 hours
join here https://t.co/nCYxRkV79w
moon dev
tweet